Upexi Seeks Shareholder Approval for 42M+ Share Issuance and Reverse Split to Avoid Nasdaq Delisting
UPXI has more than doubled off its 52-week low of $0.54.
Summary
Upexi filed a preliminary proxy seeking shareholder approval for up to 42.2 million shares issuable upon conversion of two secured convertible notes, plus authorization for a 1:2 to 1:4 reverse stock split to regain Nasdaq compliance.
Key Events · Corporate Governance and Compliance · UPXI
-
Nasdaq Rule 5635(a) Violation Determined
Nasdaq Staff determined on June 24, 2026 that the July 2025 and January 2026 secured convertible note issuances each independently violated Listing Rule 5635(a), which requires prior shareholder approval for issuances exceeding 20% of pre-transaction shares or voting power.
-
42.2M Shares Subject to Approval
Proposal 1 covers up to 35,293,205 shares issuable upon conversion of the July Notes ($151.2M principal at $4.25/share), and Proposal 2 covers approximately 6.87 million shares from the remaining $16.4M January Note principal at $2.39/share.
-
Reverse Split Authorized to Regain Compliance
Proposal 3 authorizes the Board to implement one or more reverse stock splits at a ratio of 1:2 to 1:4 over the next year, with the primary purpose of raising the stock price above Nasdaq's $1.00 minimum bid requirement.
-
Special Meeting Set for November 24, 2026
Shareholders of record as of September 25, 2026 will vote on the four proposals at a special meeting on November 24, 2026; the Board recommends voting FOR all proposals.
Analysis · UPXI · Crypto Assets
Upexi is asking shareholders to approve the potential issuance of up to 42.2 million shares — 35.3 million from the July 2025 notes and 6.87 million from the January 2026 note — to remediate a Nasdaq Listing Rule 5635(a) violation. The proxy also authorizes a reverse stock split of 1:2 to 1:4 to regain compliance with the $1.00 minimum bid price requirement. Against a backdrop of a $246.1M FY2026 net loss, negative stockholders' equity of -$53.8M, and a stock trading at $1.17, the combined dilution and reverse split signal a company fighting to maintain its Nasdaq listing while managing significant convertible debt overhang.
How filings like this one have moved
In the 30 days to Nov 2, 2026, 40.4% of the 1069 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.35%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UPXI was trading at $1.17 on NASDAQ in the Crypto Assets sector, with a market capitalization of approximately $94.4M. The 52-week trading range was $0.54 to $7.75. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.